Top deals of Oct 27-Nov 2: PharmEasy parent API raises $420.42 m

API Holdings, which runs omnichannel pharmacy chain PharmEasy, has raised $420.42 million from undisclosed investors, according to PrivateCircle Research, a private market intelligence platform. The funds were raised through an oversubscribed rights issue, said the company, as quoted by media reports. API Holdings is also the, parent of Thyrocare Technologies, Docon Technologies and other healthcare platforms.

Honasa Consumer Ltd, which runs FMCG brands such as Mamaearth and The Derma Co, closed a pre-IPO round with anchor investors, raising $91.91 million. The equity shares were allotted at the upper price band of ₹324 per share (including a premium of ₹314 apiece) with a face value of ₹10 per share. Subsequently, the skincare firm saw its initial public offering (IPO) being oversubscribed by nearly eight times on the final day.

Precision manufacturing company Aequs secured funding of $54 million from a group of investors including Sparta Group, Amansa Capital, Steadview Capital, and Catamaran Ventures. Aequs specialises in a wide range of aerospace-related services, including forging, precision machining of actuation systems, landing gear and engine components, surface treatments, and aerostructure assemblies.

Space-tech startup Skyroot Aerospace concluded a pre-Series C funding round with an investment of $27.50 million from Temasek. The company, established in 2018, will use the funding for investments in infrastructure and technology, to enhance its launch frequency, and to strengthen its team.

Ragus Healthcare, which runs healthtech startup Sugar.fit, secured $11.00 million in a Series A funding round from investors including MassMutual Ventures, Cure.fit, Tanglin Venture Partners, and Endiya Partners. Sugar.fit seeks to manage and reverse Type 2 and pre-diabetes through a"holistic, science-backed, and data-driven" digital health experience.